# A Long-term Study for the Treatment of Painful Diabetic Neuropathy

> **NCT00641719** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 258 (actual)

## Conditions studied

- Diabetic Neuropathies

## Interventions

- **DRUG:** Duloxetine hydrochloride
- **DRUG:** Duloxetine hydrochloride

## Key facts

- **NCT ID:** NCT00641719
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2011-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00641719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00641719, "A Long-term Study for the Treatment of Painful Diabetic Neuropathy". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00641719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*